Redcare Pharmacy rises after Q3 results reassure on FY targets
29/10/2025 07:52
** Shares in Redcare Pharmacy RDC.DE rise 5.5% in early Frankfurt trade after Q3 results reassure investors the German online drug retailer is on track to achieve its profit margin guidance for 2025 ** "An encouraging Q3 development with an adj. EBITDA margin of 2.4% arriving within the target corridor of 2.0-2.5% after 9M25," analysts at Jefferies say ** The company's confirmation of FY outlook eight weeks away from the end of the year signals that prescription growth will accelerate to over 150 million euros ($174.93 million) in Q4 and support investor confidence, Jefferies says ** Shares seen to top German midcap index .MDAXI ($1 = 0.8575 euros) (Reporting by Linda Pasquini) ((linda.pasquini@thomsonreuters.com))